SCHEMBL10073743

SCHEMBL10073743

CNCC(=O)N(C)c1ccc(I)c(COc2cccc3c2nc(OC)n3Cc2ccccn2)c1Cl

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 19/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659552 0.84 BDKRB2 (0.67) BDKRB2
SCHEMBL10072266 0.83 BDKRB2 (0.68) BDKRB2
SCHEMBL10072769 0.82 BDKRB2 (0.64) BDKRB2
SCHEMBL10072366 0.81 BDKRB2 (0.67) BDKRB2
SCHEMBL10072385 0.81 BDKRB2 (0.66) BDKRB2
SCHEMBL10072517 0.80 BDKRB2 (0.69) BDKRB2
SCHEMBL10074237 0.80 BDKRB2 (0.65) BDKRB2
SCHEMBL10072961 0.80 BDKRB2 (0.63) BDKRB2
SCHEMBL10072523 0.79 BDKRB2 (0.66) BDKRB2
SCHEMBL10072268 0.79 BDKRB2 (0.62) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012024419-A2 BRADYKININ RECEPTOR AGONISTS AND USES THEREOF TO TREAT OCULAR HYPERTENSION AND GLAUCOMA ALCON RESEARCH, LTD. (US) 2012-02-23 WO disclosed